Please select an option below to help us tailor your newsletter to best suit your content interests!
Our West family is so proud to support the annual Think Pink Memphis luncheon! <br> This weekend, Dr. Jason Porter and Dr. Carmel Verrier participated in the expert panel discussion, sharing information about: Screening guidelines Current treatment and surgical options Importance of physical therapy for pre- and post-surgery Resources available across the Mid-South <br> This… Read more »
Appointments Providers Patient Portal Mobile Clinic West Cancer Center & Research Institute is excited to announce the expansion of its wellness division through the acquisition of Lifesigns, beginning January 1, 2024. Dr. Bill West’s vision of outstanding patient care in this community is reflected in both centers. As the founder of West in 1979 and... Read more »
An abstract created in partnership with Dr. Gregory Vidal and Dr. Andrea Curry of our West family about Addressing Breast Cancer Disparities has been officially accepted by San Antonio Breast Cancer Symposium Alongside Rabble Health and the Urban Health Education & Support Services, this team will present methods used to measurably address social determinants of… Read more »
The Zeta Tau Alpha, Iota Xi Christian Brothers University donated these beautiful bouquets to our #BreastCancer patients yesterday afternoon! These donations are supported by their local chapters Zeta Tau Alpha Memphis Alumnae Chapter and Think Pink Memphis. Our Margaret West family is so grateful for the unwavering support of our community and partners across the… Read more »
Exciting Advances in Endocrine Therapies for Breast Cancer! 🌟 In a recent OncLive Peer Exchange, our very own Dr. Gregory Vidal shares a panel with Dr. Komal Jhaveri, Dr. Timothy Pluard, Dr. Aditya Bardia, and Dr. VK Gadi to discuss the promising landscape of novel endocrine drugs. Discussion highlights include: – The emergence of selective… Read more »
In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer. Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »
CALLING ALL REGIONAL PROVIDERS From now through November, our West family is partnering with Total Health Conferencing to host “Cancer Updates: A Dinner Series for Community Care Teams.” These dinners will consist of educational discussions designed for oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of various cancers. Each tumor-focused program is comprised… Read more »